drugset / Trial / NCT04585711
Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis
Phase 1
Withdrawn
Duke University
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · collab
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to learn more about how adult and children's bodies use etanercept and how bodyweight influences how well etanercept works. This study will help us understand the proper dose of etanercept in obese children and adults.
Timeline
- Start
- 2026-07-01
- Primary completion
- 2027-02-28
- Completion
- 2027-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | — | — |